HomeOwner SearchCategory Search
Visit USCOHuman Gene Therapy Clinical Development [Published: 2016-03-30. Issue: vol. 27, no. 1, March 2016]
Serial Registration
Copyright Title
Human Gene Therapy Clinical Development [Published: 2016-03-30. Issue: vol. 27, no. 1, March 2016]
Status
Published
on 10 Feb 2017
Year of Creation
2016
Copyright Claimant
Mary Ann Liebert Inc., publishers
Registration Number
TX0008403814
on 10 Feb 2017Copyright Summary
The U.S. Copyright record (Registration Number: TX0008403814) dated 10 Feb 2017, pertains to an electronic file (eService) titled "Human Gene Therapy Clinical Development [Published: 2016-03-30. Issue: vol. 27, no. 1, March 2016]" created in 2016. The copyright holder is Mary Ann Liebert Inc., publishers, known for their creative contributions in serial registration. For any inquiries concerning this copyrighted material, kindly reach out to Mary Ann Liebert Inc., publishers.
Application Details
Registration Number
TX0008403814
Registration Date
2/10/2017
Year of Creation
2016
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Mary Ann Liebert Inc
First Publication Nation
United States
ISSN
2324-8637
Notes
Rights Note: Cavan Patrick Slorby, Mary Ann Liebert Inc., publishers, 140 Huguenot St, New Rochelle, NY, 10801, (914) 740-2226, cslorby@liebertpub.com
Copyright Local Holdings: vol. 27, no. 1, March 2016 Created 2016 Pub. 2016-03-30 Reg. 2017-02-23 TX0008403814 PSTAN
Statements
Application Title Statement: Human Gene Therapy Clinical Development
Author Statement: Mary Ann Liebert Inc., publishers employer for hire Citizenship: United States Authorship: compilation
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.